PREVENTIVE LEG CROSSING AND OBJECTIVE ORTHOSTATIC TOLERANCE II Testing efficacy in patients with recurrent vasovagal syncope

PREVENTIVE LEG CROSSING AND OBJECTIVE ORTHOSTATIC TOLERANCE II Testing efficacy in patients with recurrent vasovagal syncope - PREVENTIVE LEG CROSSING AND OBJECTIVE ORTHOSTATIC TOLERANCE II

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON30047

Enrollment

Registered

2006-11-13

Start date

2007-01-01

Completion date

Unknown

Last updated

2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

vasovagale reacties fainting swooning vasovagale syncope

Interventions

leg crossing (physical manoeuvre)

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Age: 18-50 years;Inclusion criteria: - Clinical diagnosis of classical vasovagal syncope, based on the history and possitive tilt test or - Non-classical vasovagal syncope and a positive clinical tilt test. ;- *2 syncopic episodes in the last 2 years

Exclusion criteria

Exclusion criteria: Exclusion criteria: ;- (suspected) pregnancy - (suspected) cardiovascular disease, other than recurrent vasovagal syncope - presence of any circumstance that is likely to interfere significantly with normal orthostatic tolerance and/or the use of LBNP and/or the use of leg crossing.

Design outcomes

Primary

Measure	Time frame
Orthostatic tolerance	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)